Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 2
2018 1
2019 3
2020 8
2021 7
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean antonio scaramozzino (1 results)?
Routine vs. On-Demand Discharge Planning Strategy in Intermediate-Risk Patients for Complex Discharge: a Cluster-Randomized, Multiple Crossover Trial.
Evangelista A, Camussi E, Corezzi M, Gilardetti M, Fonte G, Scarmozzino A, La Valle G, Angelone L, Olivero E, Ciccone G, Corsi D. Evangelista A, et al. Among authors: scarmozzino a. J Gen Intern Med. 2023 Sep;38(12):2749-2754. doi: 10.1007/s11606-023-08186-4. Epub 2023 May 11. J Gen Intern Med. 2023. PMID: 37170018 Clinical Trial.
The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms.
Bertinetto FE, Magistroni P, Mazzola GA, Costa C, Elena G, Alizzi S, Scozzari G, Migliore E, Galassi C, Ciccone G, Ricciardelli G, Scarmozzino A, Angelone L, Cassoni P, Cavallo R, Vaisitti T, Deaglio S, Amoroso A; Collaborative Group. Bertinetto FE, et al. Among authors: scarmozzino a. HLA. 2023 Sep;102(3):301-315. doi: 10.1111/tan.15049. Epub 2023 Apr 3. HLA. 2023. PMID: 37010080
Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital.
Costa C, Scozzari G, Migliore E, Galassi C, Ciccone G, Ricciardelli G, Scarmozzino A, Angelone L, Cassoni P, Cavallo R, On Behalf Of The Collaborative Group. Costa C, et al. Among authors: scarmozzino a. Vaccines (Basel). 2022 Jun 27;10(7):1031. doi: 10.3390/vaccines10071031. Vaccines (Basel). 2022. PMID: 35891194 Free PMC article.
Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: An Italian cohort study.
Sacerdote C, Milani L, Castiglione A, Pagano E, Migliore E, Albera C, Bo M, Brazzi L, De Rosa FG, Durazzo M, Lupia E, Montrucchio G, Pivetta E, Porta M, Scaglione L, Veglio F, Zanierato M, Ricceri F, Caramello V, Scozzari G, Scarmozzino A; Giovannino Ciccone & COVID-EASYNET working group. Sacerdote C, et al. Among authors: scarmozzino a. J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.023. Epub 2022 Jun 30. J Infect. 2022. PMID: 35781015 Free PMC article. No abstract available.
Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers.
Costa C, Migliore E, Galassi C, Scozzari G, Ciccone G, Coggiola M, Pira E, Scarmozzino A, La Valle G, Cassoni P, Cavallo R, On Behalf Of The Collaborative Group. Costa C, et al. Among authors: scarmozzino a. Vaccines (Basel). 2022 Mar 18;10(3):474. doi: 10.3390/vaccines10030474. Vaccines (Basel). 2022. PMID: 35335105 Free PMC article.
Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy.
Scozzari G, Costa C, Migliore E, Coggiola M, Ciccone G, Savio L, Scarmozzino A, Pira E, Cassoni P, Galassi C, Cavallo R, The Collaborative Group. Scozzari G, et al. Among authors: scarmozzino a. Viruses. 2021 Jun 3;13(6):1064. doi: 10.3390/v13061064. Viruses. 2021. PMID: 34205134 Free PMC article.
25 results